MediciNova (MNOV) Projected to Post Quarterly Earnings on Thursday

MediciNova (NASDAQ:MNOV) is expected to be posting its quarterly earnings results before the market opens on Thursday, February 20th. Analysts expect MediciNova to post earnings of ($0.06) per share for the quarter.

MediciNova Stock Performance

Shares of NASDAQ:MNOV opened at $1.84 on Thursday. The company has a market capitalization of $90.25 million, a PE ratio of -8.76 and a beta of 0.82. MediciNova has a 12-month low of $1.12 and a 12-month high of $2.55. The business has a 50 day moving average of $2.03 and a two-hundred day moving average of $1.81.

Analyst Ratings Changes

A number of research firms have weighed in on MNOV. D. Boral Capital assumed coverage on shares of MediciNova in a research report on Monday, December 2nd. They set a “buy” rating and a $9.00 price objective for the company. StockNews.com started coverage on MediciNova in a report on Tuesday. They issued a “hold” rating on the stock.

MediciNova Company Profile

MediciNova, Inc, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID.